Habitual behavior and dopamine cell vulnerability in Parkinson disease

Habitual behavior and dopamine cell vulnerability in Parkinson disease

Bibliographic Details
Main Authors:	Ledia eF. Hernandez, Peter eRedgrave, Jose A Obeso
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-11-01
Series:	Frontiers in Neuroanatomy
Subjects:	Dopamine Parkinson Disease Vulnerability substantia nigra pars compacta habitual and goal-directed behaviour
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnana.2015.00146/full

Similar Items

Habitual Behavior and Dopamine Cell Vulnerability in Parkinson´s Disease
by: Ledia eF. Hernandez, et al.
Published: (2015-08-01)

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age
by: Giulia Costa, et al.
Published: (2018-05-01)

Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
by: Yi Zhang, et al.
Published: (2000-08-01)

A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
by: Vignayanandam Ravindernath-Jayashree Muddapu, et al.
Published: (2022-04-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Sporadic midbrain dopamine neuron abnormalities in laboratory mice
by: Kavita Prasad, et al.
Published: (2008-11-01)

Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human
by: Dimitri Ryczko, et al.
Published: (2017-05-01)

From the axons of the SNc dopamine neurons to their dendritic processes: further clues to susceptibility in Parkinson’s disease (PD)?
by: Eleftheria Kyriaki Pissadaki
Published: (2014-04-01)

Effects of Acupuncture on Behavioral Stereotypies and Brain Dopamine System in Mice as a Model of Tourette Syndrome
by: Lixue Lin, et al.
Published: (2019-10-01)

EL NÚCLEO PEDUNCULOPONTINO Y SU RELACIÓN CON LA FISIOPATOLOGÍA DE LA ENFERMEDAD DE PARKINSON
by: LISETTE BLANCO LEZCANO, et al.
Published: (2012-09-01)

A Multiscale, Systems-Level, Neuropharmacological Model of Cortico-Basal Ganglia System for Arm Reaching Under Normal, Parkinsonian, and Levodopa Medication Conditions
by: Sandeep Sathyanandan Nair, et al.
Published: (2022-01-01)

Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra
by: Xue Ling Liu, et al.
Published: (2020-06-01)

Effects of Chemogenetic Inhibition of D1 or D2 Receptor-Containing Neurons of the Substantia Nigra and Striatum in Mice With Tourette Syndrome
by: Lixue Lin, et al.
Published: (2021-12-01)

Proteomic Characterization of Synaptosomes from Human Substantia Nigra Indicates Altered Mitochondrial Translation in Parkinson’s Disease
by: Sarah Plum, et al.
Published: (2020-12-01)

Separate groups of dopamine neurons innervate caudate head and tail encoding flexible and stable value memories
by: Hyoung F Kim, et al.
Published: (2014-10-01)

Lesión neurotóxica unilateral del núcleo pedunculopontino: buen acercamiento a un modelo experimental presintomático de enfermedad de Parkinson en ratas
by: Lisette Blanco Lezcano, et al.
Published: (2020-12-01)

Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease
by: Naying He, et al.
Published: (2020-01-01)

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
by: Allen PF Chen, et al.
Published: (2021-06-01)

Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson’s Disease
by: Gian-Carlo Eyer, et al.
Published: (2021-11-01)

Parkinson’s Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy
by: Smriti Sinha, et al.
Published: (2021-09-01)

Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
by: Carmela Conte, et al.
Published: (2023-05-01)

Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA Rat Model of Parkinson's Disease
by: Jordi Boix, et al.
Published: (2018-03-01)

Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach
by: Mojtaba Jokar, et al.
Published: (2023-02-01)

Gentle handling temporarily increases c-Fos in the substantia nigra pars compacta
by: C.A. Santos, et al.
Published: (2008-10-01)

Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
by: Marie-Thérèse Armentero, et al.
Published: (2006-12-01)

Natural apoptosis in developing mice dopamine midbrain neurons and vermal Purkinje cells
by: Joaquín Martí-Clúa
Published: (2016-06-01)

The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson's disease rat model
by: Xiaoyu Liu, et al.
Published: (2023-06-01)

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
by: V. Rizelio, et al.
Published: (2010-01-01)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
by: Lars eBrichta, et al.
Published: (2014-12-01)

Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia
by: Peggy Rentsch, et al.
Published: (2019-02-01)

A Multi-Scale Computational Model of Excitotoxic Loss of Dopaminergic Cells in Parkinson's Disease
by: Vignayanandam Ravindernath Muddapu, et al.
Published: (2020-09-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion
by: Lisette Blanco-Lezcano, et al.
Published: (2018-02-01)

Racing and Pacing in the Reward System: A Multi-Clock Circadian Control Over Dopaminergic Signalling
by: Kamil Pradel, et al.
Published: (2022-06-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

Nigral volumetric and microstructural measures in individuals with scans without evidence of dopaminergic deficit
by: Jason Langley, et al.
Published: (2022-11-01)

A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity
by: Vignayanandam Ravindernath Muddapu, et al.
Published: (2019-02-01)

Dopaminergic nuclei in the chick midbrain express serotonin receptor subfamily genes
by: Toshiyuki Fujita, et al.
Published: (2022-11-01)

Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice
by: Alexander Pilski, et al.
Published: (2023-08-01)

Application of the Catecholaminergic Neuron Electron Transport (CNET) Physical Substrate for Consciousness and Action Selection to Integrated Information Theory
by: Chris Rourk
Published: (2022-01-01)